Decibel Announces 27 New Upcoming Ontario Product Launches
Ryan Allway September 22nd, 2021 News, Top News CALGARY, AB, Sept. 22, 2021 /PRNewswire/ – Decibel Cannabis Company Inc. (the “Company” or “Decibel”) (TSXV: DB) (OTCQB: DBCCF), a premium cannabis producer, is pleased to announce its recent success in the Ontario product call as well as upcoming Ontario product launches with 27 new product introductions over... Read more
Ryan Allway September 20th, 2021 News, Top News VANCOUVER, BC, Sept. 20, 2021 /PRNewswire/ – PODA LIFESTYLE AND WELLNESS LTD. (“Poda” or the “Company”) (CSE: PODA) (FSE: 99L) (OTC: PODAF) is pleased to announce that its CEO, Mr. Ryan Selby, and Mr. Nicholas Kadysh, member of Poda’s Strategic Advisory Board, will be attending the Global... Read more
Enveric Biosciences Announces Closing of MagicMed Industries Acquisition
Ryan Allway September 17th, 2021 Psychedelics, Top News Enveric intends to immediately accelerate the development of a novel Psychedelic molecule for Cancer Related Distress NAPLES, Fla., Sept. 17, 2021 /PRNewswire/ — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-centric biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer... Read more
Decibel Closes Previously Announced Offering of Units for Total Gross Proceeds of Approximately $15 Million, including Full Exercise of Over-Allotment Option
Ryan Allway September 16th, 2021 News, Top News CALGARY, AB, Sept. 16, 2021 /CNW/ – Decibel Cannabis Company Inc. (“Decibel” or the “Company“) (TSXV: DB) (OTCQB: DBCCF), a premium cannabis producer, is pleased to announce the closing of its previously announced bought deal prospectus offering (the “Offering“) of units of the Company (“Units“).... Read more
Enveric & MagicMed: Combining Drug Discovery with Clinical Expertise
Ryan Allway September 9th, 2021 Psychedelics, Top News Enveric Biosciences Inc.’s (NASDAQ: ENVB) focus has been on discovering and developing cannabinoid-based therapeutics for patients suffering from the side effects of cancer treatments. With the acquisition of MagicMed Industries, the company also sees an opportunity in cancer-related distress from anxiety,... Read more
Algernon Pharmaceuticals Confirms DMT Increased Growth of Neurons by 40% in Preclinical Study at Sub Hallucinogenic Dose
VANCOUVER, British Columbia, Sept. 07, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that it has confirmed in its own preclinical study, that AP-188 (“N,N-Dimethyltryptamine or “DMT”), increased the growth... Read more
Filament Health Shares to Commence Trading on the OTC Market
VANCOUVER, BC, Sept. 7, 2021 /CNW/ – Filament Health Corp. (NEO: FH) (OTC Pink: FLHLF) (“Filament” or the “Company”), an exclusively-natural psychedelic drug discovery company, today announced that it received notification from the Financial Regulatory Authority (“FINRA”) that its shares are qualified to commence trading on the OTC Pink Market (the... Read more
TerrAscend to Acquire Gage Cannabis
Ryan Allway September 1st, 2021 News, Top News Establishes Leading Presence in Michigan, the Third Largest U.S. Cannabis Market Combines Industry Leading Retail, Cultivation and Operations Teams Across 7 Cultivation Facilities and 23 Operational Retail Locations in 5 States The Gage Brand, One of the Most Influential and Innovative in Michigan,... Read more
Ketamine One to Deploy Cognetivity’s Integrated Cognitive Assessment Tool
VANCOUVER, British Columbia, Sept. 01, 2021 (GLOBE NEWSWIRE) — KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0) , a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased to announce that it has reached a commercial... Read more
BioHarvest Sciences Inc. Successfully Delivers A Major Milestone In The Scale-up Process Of Its Cannabis Development Program
Ryan Allway September 1st, 2021 – The Company is now growing Cannabis cells with trichomes in medium-scale bioreactors representing a 250x increase in scale – On track for commercialization of Cannabis and Hemp based products in H1-2022 VANCOUVER, BC and REHOVOT, Israel, Sept. 1, 2021 /CNW/ — BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) is... Read more

( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )